Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    Centor Score (Modified/McIsaac) for Strep Pharyngitis

    Estimates probability that pharyngitis is streptococcal, and suggests management course.

    IMPORTANT

    We launched a COVID-19 Resource Center, including a critical review of recommended calcs.

    INSTRUCTIONS

    Use only in patients with recent onset (≤3 days) acute pharyngitis.

    When to Use
    Pearls/Pitfalls
    Why Use

    Children with pharyngitis, primarily; the risk of GAS decreases significantly with age into adulthood.

    • The Centor Score correlates directly with risk of positive throat culture for GAS (Group A Streptococcus).
    • New 2012 guidelines from the IDSA (Infectious Disease Society of America) no longer recommend empiric treatment for patients alone; they recommend testing patients that are at higher risk for strep pharyngitis, but not giving antibiotics until a rapid test is positive or a throat culture is positive.
    • The modified criteria by McIsaac et al include an age component, along with tonsillar swelling, as part of the rule. GAS is incredibly rare in patients under 3 and less common in older adults, so this can help clinicians risk stratify patients.
    • Most cases of pharyngitis are viral in origin, and with the rare incidence of rheumatic fever, along with the questionable benefits of early antibiotics to prevent sequelae like peritonsillar abscess, antibiotics are prescribed much less often. Steroids (like dexamethasone) and NSAIDS often provide similar pain relief and resolution of symptoms to antibiotics.
    • Most pharyngitis is viral and does not respond to antibiotic treatment. The Centor Score attempts to predict which patients will have culture-confirmed streptococcal infections of their pharynx to help determine which patients to test in the first place.
    • The newer FeverPAIN Score is similar, but the Centor Score has the distinguishes between adolescents and young adults from pre-adolescents—important because strep carrier rates are higher in preadolescents than adolescents/young adults, and older patients are more likely to have severe symptoms and develop suppurative complications (Mitchell 2011).
    3-14 years
    +1
    15-44 years
    0
    ≥45 years
    -1
    No
    0
    Yes
    +1
    No
    0
    Yes
    +1
    No
    0
    Yes
    +1
    Cough present
    0
    Cough absent
    +1
    Confirmed positive
    Suspected
    Unlikely
    Confirmed negative

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights
    Dr. Robert M. Centor

    From the Creator

    Why did you develop the Centor Score? Was there a clinical experience that inspired you to create this tool for clinicians?
    In 1979, while working in the "non-acute" adult emergency room, a resident asked me how to evaluate a sore throat patient. Having just finished my residency, I started to give a definitive answer, but had a moment of humility and told him that I did not know. We made a treatment decision at the time, and I went to the library to learn more. A wonderful microbiologist agreed to do some throat cultures for us, and I developed a questionnaire. Our goal was to see if clinical findings could stratify the probability that an adult (16 and older in our ER) patient had group A Strep.

    What pearls, pitfalls and/or tips do you have for users of the Centor Score? Are there cases when it has been applied, interpreted, or used inappropriately?
    We studied adults, and thus have always been wary of applying it to children. More recently, we have published a review that shows that pre-adolescent pharyngitis has many differences from adolescent/young adult pharyngitis. McIsaac has developed an adjustment for age which might be appropriate for pre-adolescents.

    Please do not use this score if the patient does not have a recent onset acute pharyngitis (3 days or less). Some have erred in using this for any throat discomfort.

    What recommendations do you have for health care providers once they have the Centor Score result? Are there any adjustments or updates you would make to the score given recent changes in medicine?
    Our recent research suggests that our Score stratifies not just group A strep, but also groups C&G strep and Fusobacterium necrophorum. Because we believe that we should treat all of these bacteria, we favor narrow antibiotics (preferably penicillin, amoxicillin or a narrow spectrum cephalosporin) for scores of 3 or 4. Depending on clinical assessment, we sometimes will also treat the 2s. Zeros and 1s need no testing or antibiotics. All patients should be told that pharyngitis is generally self limited and should improve over the next 2-5 days. If symptoms worsen, then the differential diagnosis broadens and the score is not longer relevant. Major red flags include rigors and inability to swallow secondary to pain. These patients need further evaluation, and likely hospitalization.

    Any further research you're working on related to resource utilization and sore throat?
    We continue to study the importance of Fusobacterium necrophorum, an obligate anaerobe that causes endemic pharyngitis in adolescents and young adults. This bacteria is very important because it is the most common cause of peritonsillar abscess in the 15-30 age group, and the primary cause of Lemierre Syndrome.

    About the Creator

    Robert M. Centor, MD, is the retired regional dean for the Huntsville Regional Medical and professor of medicine in the Division of General Internal Medicine at the University of Alabama at Birmingham. He researches medical decision-making and has published widely in the diagnosis and management of adult sore throats. Dr. Centor is also Chair Emeritus of the Board of Regents for the American College of Physicians.

    To view Dr. Robert M. Centor's publications, visit PubMed

    Are you Dr. Robert M. Centor? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
    MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.
    Dr. Warren McIsaac

    About the Creator

    Warren McIsaac, MD, MSc, is a family physician and an associate professor in the department of family and community medicine at the University of Toronto. He is also the research director of the Granovsky Gluskin Family Medicine Centre. Dr. McIsaac’s research interests include antibiotic resistance, antimicrobial stewardship, and prescribing decisions in primary care.

    To view Dr. Warren McIsaac's publications, visit PubMed

    Are you Dr. Warren McIsaac? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
    MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.
    About the Creator
    Dr. Robert M. Centor
    Are you Dr. Robert M. Centor?
    Dr. Warren McIsaac
    Are you Dr. Warren McIsaac?
    Partner Content